ANTI CANCER MEDICATION
250 mg Herduo Lapatinib I.P. Tablets
Price on Request
Herduo 250 mg Tablets (containing the active ingredient Lapatinib I.P.) are a targeted anti-cancer medication prescribed for the treatment of advanced or metastatic HER2-positive breast cancer. Manufactured by Natco Pharma, it works by inhibiting the overproduction of EGFR and HER2 proteins to slow or stop cancer cell growth.
liketo.usa,uk,china,southkorea,russia,japan,singapore
liketo.usa,uk,china,southkorea,russia,japan,singapore
Composition
Packaging Size 30 Tablets
Strength 250 mg
Pack Size 30 Tablets
Form Tablet
Usage HER2+ Breast Ca, Breast Cancer
Manufactured By Natco
Country of Origin Made in India
Composition Lapatinib Tablets IP
Brand Herduo
Packaging Type Box
Treatment Breast cancer
Minimum order quantity: 50 Bottle
Enquire About This Product